Correlation Between Lyra Therapeutics and DBV Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and DBV Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and DBV Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and DBV Technologies, you can compare the effects of market volatilities on Lyra Therapeutics and DBV Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of DBV Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and DBV Technologies.

Diversification Opportunities for Lyra Therapeutics and DBV Technologies

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Lyra and DBV is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and DBV Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DBV Technologies and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with DBV Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DBV Technologies has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and DBV Technologies go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and DBV Technologies

Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 1.42 times more return on investment than DBV Technologies. However, Lyra Therapeutics is 1.42 times more volatile than DBV Technologies. It trades about -0.02 of its potential returns per unit of risk. DBV Technologies is currently generating about -0.04 per unit of risk. If you would invest  268.00  in Lyra Therapeutics on September 2, 2024 and sell it today you would lose (247.00) from holding Lyra Therapeutics or give up 92.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Lyra Therapeutics  vs.  DBV Technologies

 Performance 
       Timeline  
Lyra Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
DBV Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DBV Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, DBV Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Lyra Therapeutics and DBV Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lyra Therapeutics and DBV Technologies

The main advantage of trading using opposite Lyra Therapeutics and DBV Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, DBV Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will offset losses from the drop in DBV Technologies' long position.
The idea behind Lyra Therapeutics and DBV Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance